The role of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in human esophageal cancer

Anticancer Research

Volumn 24, Issue 5 A, 2004, Pages 3029-3034

  Sohda, Makoto ^a   Kato, Hiroyuki ^a   Miyazaki, Tatsuya ^a   Nakajima, Masanobu ^a   Fukuchi, Minoru ^a   Manda, Ryokuhei ^a   Fukai, Yasuyuki ^a   Masuda, Norihiro ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

ELISA; Esophageal carcinoma; IGF 1; IGFBP 3

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; BLOOD LEVEL; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; LIGAND CAPTURE IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

ADULT; AGED; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 6444232837     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. LeRoith D, Beserga R, Helman L et al: Insulin-like growth factors and cancer. Ann Intern Med 22: 54-59, 1995.
2. LeRoith D, Clemmons D, Nissley P et al: NIH conference. Insulin-like growth factors in health and disease. Ann Intern Med 116: 854-862, 1992.
3. Daughaday WH: The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127: 1-4, 1990.
4. Le Roith D: Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 336: 633-640, 1997.
5. Chan JM, Stampfer MJ, Giovannucci E et al: Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566, 1998.
6. Toniolo P, Bruning PF, Akhmedkhanov A et al: Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88: 828-832, 2000.
7. Yu H, Levesque MA, Khosravi MJ et al: Insulin-like growth factor-binding protein-3 and breast cancer survival. Int J Cancer 79: 624-628, 1998.
8. Katsaros D, Yu H, Levesque MA et al: IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival. Eur J Cancer 37: 478-485, 2001.
9. Katsaros D, Yu H, Piccinno R et al: IGFBP-3. Expression and prognostic significance in epithelial ovarian cancer. Minerva Ginecol 54: 15-24, 2002.
10. Yu H, Jin F, Shu XO et al: Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 11: 705-712, 2002.
11. Ma J, Pollak MN, Giovannucci E et al: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91: 620-625, 1999.
12. Silva Filho GB, Maciel RM, Takahashi MH et al: Study of immunohistochemical expression of insulin-like growth factor I and proliferating cell nuclear antigen in thyroid gland papillary carcinoma and its metastasis. Head Neck 21: 723-727, 1999.
13. Oku K, Tanaka A, Yamanishi H et al: Effects of various growth factors on growth of a cloned human esophageal squamous cancer cell line in a protein-free medium. Anticancer Res 11: 1591-1595, 1991.
14. Iihara K, Shiozaki H, Oku K et al: Growth-regulatory mechanism of two human esophageal-cancer cell lines in protein-free conditions. Int J Cancer 55: 364-370, 1993.
15. Chen SC, Chou CK, Wong FH et al: Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells. Cancer Res 51: 1898-1903, 1991.
16. Miyazaki T, Kato H and Shitara Y: Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer 89: 955-962, 2000.